Trademark: 97291156
Status Date
Wednesday, January 24, 2024
Filing Date
Wednesday, March 2, 2022
Published for Opposition
Tuesday, January 24, 2023
5 pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Extension 2 Granted
Jan 24, 2024
Sou Extension 2 Filed
Jan 24, 2024
Sou Teas Extension Received
Sep 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2023
Sou Extension 1 Granted
Sep 6, 2023
Sou Extension 1 Filed
Sep 6, 2023
Sou Teas Extension Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 21, 2022
Approved For Pub - Principal Register
Dec 14, 2022
Assigned To Examiner
Mar 7, 2022
New Application Office Supplied Data Entered
Mar 5, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24